Clinical Trials Browser

Phase 3 × Prostatic Neoplasms × Ipilimumab × Clear all

NCT00861614 2016-09-30

Study of Immunotherapy to Treat Advanced Prostate Cancer

Phase 3 Completed

988 enrolled 19 charts

Prostatic Neoplasms

NCT01057810 2016-08-18

Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer

Phase 3 Completed

837 enrolled 15 charts

Prostatic Neoplasms